Veritable’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-7,629
Closed -$213K 910
2022
Q4
$213K Buy
+7,629
New +$195K ﹤0.01% 792
2022
Q3
Sell
-9,508
Closed -$321K 862
2022
Q2
$321K Buy
9,508
+191
+2% +$6.69K 0.01% 658
2022
Q1
$325K Sell
9,317
-170
-2% -$5.81K 0.01% 694
2021
Q4
$289K Sell
9,487
-809
-8% -$26.4K ﹤0.01% 730
2021
Q3
$338K Sell
10,296
-3,260
-24% -$104K 0.01% 653
2021
Q2
$410K Buy
+13,556
New +$446K 0.01% 591

Other funds holding OGN

Veritable's OGN Position: Q1 2023 in Review

Veritable sold out of Organon & Co (OGN) in Q1 2023, closing a stake of 7,629 shares — an estimated $213K sold.

Veritable first reported a position in OGN in Q2 2021 and held it in 6 quarters. The position peaked at $410K in Q2 2021. 767 funds tracked by Wall St. Rank hold OGN as of Q1 2023.

  • Veritable reported no remaining Organon & Co position as of Q1 2023 after selling out during the quarter.
  • Veritable sold 7,629 Organon & Co shares in Q1 2023, an estimated $213K.
  • Veritable first reported a position in Organon & Co in Q2 2021 and held it in 6 quarters.
  • Veritable's Organon & Co position peaked at $410K in Q2 2021.
  • 767 funds tracked by Wall St. Rank held Organon & Co as of Q1 2023.

Based on Veritable's 13F filing for Q1 2023, filed 12 May 2023.